Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia J Tifft

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|January 31, 2024
<i>N</i>-Acetyl-l-Leucine and Neurodegenerative DiseaseCynthia J Tifft
JAMA|May 12, 2011
The NIH Undiagnosed Diseases Program: lessons learnedWilliam A Gahl, Cynthia J Tifft
Current Opinion in Pediatrics|October 15, 2014
The National Institutes of Health undiagnosed diseases programCynthia J Tifft, David R Adams
Neuroscience Letters|August 27, 2021
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatmentCamilo Toro, Mosufa Zainab, Cynthia J Tifft
Clinical Dysmorphology|March 14, 2009
Dysmorphic findings in two cases of abeta/hypobetalipoproteinemiaBenjamin D Solomon, Parvathi Mohan, Cynthia J Tifft
Clinical Biochemistry|February 5, 2008
Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometryJianghong Gu, Cynthia J Tifft, Steven J Soldin
Translational Science of Rare Diseases|June 2, 2020
The undiagnosed diseases program: Approach to diagnosisEllen F Macnamara, Precilla D'Souza, , et al.
Frontiers in Neuroimaging|February 28, 2025
Editorial: Role of neuroimaging in the diagnosis and treatment of rare diseasesMohammed Salman Shazeeb, Maria T Acosta, Cynthia J Tifft
Journal of Lipid Research|January 27, 2019
A perilous path: the inborn errors of sphingolipid metabolismTeresa M Dunn, Cynthia J Tifft, Richard L Proia
Orphanet Journal of Rare Diseases|August 5, 2020
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)Elin Haf Davies, Jean Johnston, Camilo Toro, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|January 31, 2024
<i>N</i>-Acetyl-l-Leucine and Neurodegenerative DiseaseCynthia J Tifft
JAMA|May 12, 2011
The NIH Undiagnosed Diseases Program: lessons learnedWilliam A Gahl, Cynthia J Tifft
Current Opinion in Pediatrics|October 15, 2014
The National Institutes of Health undiagnosed diseases programCynthia J Tifft, David R Adams
Neuroscience Letters|August 27, 2021
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatmentCamilo Toro, Mosufa Zainab, Cynthia J Tifft
Clinical Dysmorphology|March 14, 2009
Dysmorphic findings in two cases of abeta/hypobetalipoproteinemiaBenjamin D Solomon, Parvathi Mohan, Cynthia J Tifft
Clinical Biochemistry|February 5, 2008
Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometryJianghong Gu, Cynthia J Tifft, Steven J Soldin
Translational Science of Rare Diseases|June 2, 2020
The undiagnosed diseases program: Approach to diagnosisEllen F Macnamara, Precilla D'Souza, , et al.
Frontiers in Neuroimaging|February 28, 2025
Editorial: Role of neuroimaging in the diagnosis and treatment of rare diseasesMohammed Salman Shazeeb, Maria T Acosta, Cynthia J Tifft
Journal of Lipid Research|January 27, 2019
A perilous path: the inborn errors of sphingolipid metabolismTeresa M Dunn, Cynthia J Tifft, Richard L Proia
Orphanet Journal of Rare Diseases|August 5, 2020
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)Elin Haf Davies, Jean Johnston, Camilo Toro, et al.
Pageof 13